Ñî¹óåú´«Ã½Ò•îl

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Ñî¹óåú´«Ã½Ò•îl Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Apr 7 2026

Full Issue

Penicillin Allergy Testing Can Now Be Done As Part Of Routine Hospital Care

An international study found that about 95% of people labeled as allergic to penicillin were misdiagnosed as children or have grown out of the allergy. A smartphone app assesses patients' risk, and those deemed to have a low-risk penicillin allergy can be offered a direct oral challenge — a penicillin antibiotic — and observed for a possible reaction.

Most patients who have been labelled allergic to penicillin probably aren't, according to a new study from Australian researchers. The study, led by Austin Health in collaboration with the University of Melbourne, drew results from more than 5,000 patients internationally. (Westerholm, 4/6)

Results from a multinational study indicate that direct oral challenge (DOC) is a safe and effective strategy for identifying hospital patients who truly have a penicillin allergy, researchers reported last week in Clinical Infectious Diseases. (Dall, 4/6)

In other health and wellness news —

A quarter of older adults on hypothyroidism medication were able to wean off of it while maintaining adequate thyroid function, an open-label prospective study showed. (Monaco, 4/6)

Christos Soteriou was 29 when he needed a quadruple bypass surgery. Four arteries in his heart had become so clogged with plaque that blood could no longer flow through them. It’s a surprisingly young age to need such a surgery, but extremely high levels of cholesterol run in Soteriou’s family — a genetic condition called familial hypercholesterolemia. His father died of heart disease at 46; his son was diagnosed with elevated cholesterol at 14; and Soteriou himself, now 51, has had two heart attacks since his operation. (Cox, 4/6)

Do you get dizzy while looking at your phone while riding as a passenger in a car? That could be a sign of motion sickness, a common, yet complex, condition that can have varying severities of symptoms to go along with it. Managing the symptoms can involve sitting in certain seats in moving vehicles, hydration, avoiding empty or too full of a stomach, or even avoiding triggering events like amusement parks, large movie theater screens or even just putting your phone down while in a car. (Cisneros, 4/4)

A growing number of teenage boys are chasing dramatic body transformations online — building massive muscles, shedding fat and documenting it all for millions to see. But behind some of the viral physiques lies a troubling trend: the use of a powerful drug never approved for humans. (Yamaguchi and Baek, 4/6)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
More Morning Briefings
RSS Feeds
  • Ñî¹óåú´«Ã½Ò•îl
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF